2. Signaling Pathways
  3. Others
  4. MOFs

MOFs

Metal-Organic Frameworks

MOFs (Metal-Organic Frameworks) have significant applications in biomedicine, such as serving as drug carriers for targeted delivery and controlled release to enhance therapeutic efficacy and reduce side effects. They are also used in bioimaging, disease diagnosis, and catalytic therapies (e.g., for cancer treatment).

MOFs Related Products (3078):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W456450
    4-((1H-Imidazol-1-yl)methyl)pyridine
    4-((1H-Imidazol-1-yl)methyl)pyridine is a metal-organic framework (MOF).
    4-((1H-Imidazol-1-yl)methyl)pyridine
  • HY-W124414
    5'-(4-Sulfophenyl)-[1,1':3',1''-terphenyl]-4,4''-disulfonic acid
    5'-(4-Sulfophenyl)-[1,1':3',1''-terphenyl]-4,4''-disulfonic acid is a metal-organic framework (MOF).
    5'-(4-Sulfophenyl)-[1,1':3',1''-terphenyl]-4,4''-disulfonic acid
  • HY-W002957
    4-(1H-1,2,4-triazol-1-yl)benzoic acid
    4-(1H-1,2,4-triazol-1-yl)benzoic acid is a metal-organic framework (MOF).
    4-(1H-1,2,4-triazol-1-yl)benzoic acid
  • HY-W075165
    2-(Pyridin-4-yl)terephthalic acid
    2-(Pyridin-4-yl)terephthalic acid (6-(4-Pyridyl)terephthalic acid) is a metal-organic framework (MOF).
    2-(Pyridin-4-yl)terephthalic acid
  • HY-W112608
    2,6-Bis((3,5-dimethyl-1H-pyrazol-1-yl)methyl)pyridine
    2,6-Bis((3,5-dimethyl-1H-pyrazol-1-yl)methyl)pyridine is a metal-organic framework (MOF).
    2,6-Bis((3,5-dimethyl-1H-pyrazol-1-yl)methyl)pyridine
  • HY-W657003
    1,3-Bis[4-(4-Pyridyl)-2-thiazolyl]benzene
    1,3-Bis[4-(4-Pyridyl)-2-thiazolyl]benzene is a metal-organic framework (MOF).
    1,3-Bis[4-(4-Pyridyl)-2-thiazolyl]benzene
  • HY-W586864
    4′-(4-Carboxyphenoxy)[1,1′-biphenyl]-4-carboxylic acid
    4′-(4-Carboxyphenoxy)[1,1′-biphenyl]-4-carboxylic acid is a metal-organic framework (MOF).
    4′-(4-Carboxyphenoxy)[1,1′-biphenyl]-4-carboxylic acid
  • HY-W856203
    5-(3,5-Dimethyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid
    5-(3,5-Dimethyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid is a metal-organic framework (MOF).
    5-(3,5-Dimethyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid
  • HY-W543297
    1H-​Imidazolium,3,​3'-​methylenebis[1-​(4-​carboxy-​2-​methylphenyl)​-​,chloride(1:2)
    1H-?Imidazolium,3,?3'-?methylenebis[1-?(4-?carboxy-?2-?methylphenyl)?-?,chloride(1:2) is a metal-organic framework (MOF).
    1H-​Imidazolium,3,​3'-​methylenebis[1-​(4-​carboxy-​2-​methylphenyl)​-​,chloride(1:2)
  • HY-W856181
    4,4'-Dichloro-[1,1'-biphenyl]-2,2'-dicarboxylic acid
    4,4'-Dichloro-[1,1'-biphenyl]-2,2'-dicarboxylic acid is a metal-organic framework (MOF).
    4,4'-Dichloro-[1,1'-biphenyl]-2,2'-dicarboxylic acid
  • HY-W456532
    4,4'-(1,4-Phenylenebis(oxy))diphthalic acid
    4,4'-(1,4-Phenylenebis(oxy))diphthalic acid is a metal-organic framework (MOF).
    4,4'-(1,4-Phenylenebis(oxy))diphthalic acid
  • HY-W998822
    3,6-Dibutylphthalonitrile
    3,6-Dibutylphthalonitrile is a metal-organic framework (MOF).
    3,6-Dibutylphthalonitrile
  • HY-W112071
    Tris(4-(3-methylthiophene-2-yl)phenyl)amine
    Tris(4-(3-methylthiophene-2-yl)phenyl)amine is a metal-organic framework (MOF).
    Tris(4-(3-methylthiophene-2-yl)phenyl)amine
  • HY-W251505
    2-Boronoterephthalic acid
    2-Boronoterephthalic acid(2-Borono-1,4-benzenedicarboxylic acid) is a metal-organic framework (MOF).
    2-Boronoterephthalic acid
  • HY-W044457
    2-(4-Fluorophenyl)-1H-imidazole
    2-(4-Fluorophenyl)-1H-imidazole (2-(4-Fluoro-Phenyl)-1H-Imidazole) is a metal-organic framework (MOF).
    2-(4-Fluorophenyl)-1H-imidazole
  • HY-W075451
    5,5'-Di(1H-1,2,4-triazol-1-yl)-[1,1'-biphenyl]-3,3'-dicarboxylic acid
    5,5'-Di(1H-1,2,4-triazol-1-yl)-[1,1'-biphenyl]-3,3'-dicarboxylic acid is a metal-organic framework (MOF).
    5,5'-Di(1H-1,2,4-triazol-1-yl)-[1,1'-biphenyl]-3,3'-dicarboxylic acid
  • HY-W112321
    5-((Bis(carboxymethyl)amino)methyl)isophthalic acid
    5-((Bis(carboxymethyl)amino)methyl)isophthalic acid is a metal-organic framework (MOF).
    5-((Bis(carboxymethyl)amino)methyl)isophthalic acid
  • HY-107603
    NS3763
    NS3763 is a selective and noncompetitive GLUK5 receptor antagonist with an IC50 of 1.6 µM. NS3763 does not show significant antagonistic properties on GLUK6, AMPA or NMDA receptors.
    NS3763
  • HY-W456565
    (E)-2-(4-((4-Butylphenyl)diazenyl)phenoxy)-N,N,N-trimethylethanaminium bromide
    (E)-2-(4-((4-Butylphenyl)diazenyl)phenoxy)-N,N,N-trimethylethanaminium bromide ((E)-2-(4-((4-Butylphenyl)diazenyl)phenoxy)-N,N,N-trimethylethan-1-aminium,bromide) is a metal-organic framework (MOF).
    (E)-2-(4-((4-Butylphenyl)diazenyl)phenoxy)-N,N,N-trimethylethanaminium bromide
  • HY-W249348
    N1,N1,N4,N4-Tetrakis(4-(4H-1,2,4-triazol-4-yl)phenyl)benzene-1,4-diamine
    N1,N1,N4,N4-Tetrakis(4-(4H-1,2,4-triazol-4-yl)phenyl)benzene-1,4-diamine is a metal-organic framework (MOF).
    N1,N1,N4,N4-Tetrakis(4-(4H-1,2,4-triazol-4-yl)phenyl)benzene-1,4-diamine